<![CDATA[Invasive Lobular Carcinoma: Diagnosis, Trials and What's Changing]]>

Summary

A multidisciplinary panel discussion covered invasive lobular carcinoma biology, imaging challenges, and emerging trial data from OFSET and SUMMIT studies. No specific company, drug, or trial outcomes are identified in this article.